Cargando…
Establishment and Validation of a Gene Signature-Based Prognostic Model to Improve Survival Prediction in Adrenocortical Carcinoma Patients
BACKGROUND: The current guideline for the management of adrenocortical carcinoma (ACC) is insufficient for accurate risk prediction to guide adjuvant therapy. Given frequent and severe therapeutic side effects, a better estimate of survival is warranted for risk-specific assignment to adjuvant treat...
Autores principales: | Ge, Xiaoqin, Liu, Zhenzhen, Jiao, Xuehua, Yin, Xueyan, Wang, Xiujie, Li, Gengxu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632466/ https://www.ncbi.nlm.nih.gov/pubmed/34858497 http://dx.doi.org/10.1155/2021/2077633 |
Ejemplares similares
-
SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019) -
The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma
por: Gao, Jun, et al.
Publicado: (2023) -
Establishment of prognostic models of adrenocortical carcinoma using machine learning and big data
por: Tang, Jun, et al.
Publicado: (2023) -
A transcription factor signature predicts the survival of patients with adrenocortical carcinoma
por: Zhao, Jianyu, et al.
Publicado: (2021) -
Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)